South & Central America Organ Preservation Solutions Market
CVDs are heart and blood vessel disorders, which include cerebrovascular diseases, coronary heart disease, rheumatic heart disease, and other diseases. Tobacco use, unhealthy diet, and physical inactivity increase the risk of heart attacks and strokes.
Cardiovascular diseases are becoming more and more prevalent worldwide. Cardiovascular diseases are the world's leading cause of death. Most CVD deaths are followed by a stroke and heart failure due to coronary heart disease (CHD). It is also stated that ~31% of all deaths are caused by cardiovascular diseases worldwide. According to organdonor.gov, the heart is the third-largest vital organ transplantation performed after kidney and liver. Besides, new technologies for a heart transplant will offer lucrative opportunities for the organ preservation solutions market. Technological innovation has been playing a critical role in increasing the widespread uptake of organ transplantation. For instance, the Transmedics Organ Care System (OCS) Heart, or "Heart in a Box," enables transplant doctors to travel to much farther locations in search of transplant hearts by acting as a miniature intensive care unit that maintains the heart's viability.
The increasing need for a heart transplant, owing to the rising prevalence of cardiovascular diseases, is expected to boost the market growth during the prediction period.
South and Central America consists of Brazil, Argentina, and the Rest of SCAM. Brazil is expected to have the major market share in this region. Developing healthcare facilities, increasing incidence of hypertension, rising geriatric population, and increasing incidence of kidney and heart diseases are expected to fuel the organ preservation solutions market growth.
The prevalence of hypertension has been linked to the aging population in Brazil. Estimates from the Brazilian Institute of Geography and Statistics (IBGE) indicate that, by 2060, people over 65 years old will account for 25.5% of the population. The rising geriatric population is expected to result in a high prevalence of kidney failure. The majority of the CKD burden is met by low- and middle-income countries. Sepsis is the leading cause of death in intensive care units in Brazil. Many studies have revealed that the incidence of the disease is growing over time, and there is only a slight reduction in mortality. The Sepsis Prevalence Assessment Database Project (SPREAD), a statewide 1-day point prevalence survey of Brazilian intensive care units (ICUs), found a sepsis incidence of 36.3 cases per 1,000 patient days and a shocking hospital mortality rate of 55.7%.
Strategic insights for the South & Central America Organ Preservation Solutions provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 19.58 Million |
| Market Size by 2028 | US$ 27.37 Million |
| Global CAGR (2023 - 2028) | 6.9% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
The geographic scope of the South & Central America Organ Preservation Solutions refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The South & Central America organ preservation solution market is segmented into type, application, organ type, end user, and country.
Based on type, the South & Central America organ preservation solution market is segmented into University of Wisconsin solution, custodiol htk, perfadex, hypothermosol, and others. The University of Wisconsin solution segment registered the largest South & Central America organ preservation solution market share in 2023.
Based on application, the South & Central America organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest South & Central America organ preservation solution market share in 2023.
Based on organ type, the South & Central America organ preservation solutions market is segmented into kidneys, liver, lungs, heart, and others. The kidney segment held the largest South & Central America organ preservation solution market share in 2023.
Based on end user, the South & Central America organ preservation solutions market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest South & Central America organ preservation solution market share in 2023.
Based on country, the South & Central America organ preservation solutions market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America organ preservation solutions market share in 2023.
Accord Healthcare; Dr. Franz Koehler Chemie GmbH; Lifeline Scientific, Inc; and TransMedics are the leading companies operating in the South & Central America organ preservation solutions market in the region.
The South & Central America Organ Preservation Solutions Market is valued at US$ 19.58 Million in 2023, it is projected to reach US$ 27.37 Million by 2028.
As per our report South & Central America Organ Preservation Solutions Market, the market size is valued at US$ 19.58 Million in 2023, projecting it to reach US$ 27.37 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.
The South & Central America Organ Preservation Solutions Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Organ Preservation Solutions Market report:
The South & Central America Organ Preservation Solutions Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Organ Preservation Solutions Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Organ Preservation Solutions Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Organ Preservation Solutions Market
